Why Prime Medicine, Inc. (PRME) stock fell 9.7% on Tuesday, November 10, 2026

Prime Medicine, Inc. (PRME) traded at $3.89 as of 11:31 AM ET, down 9.65% on Tuesday, November 10, 2026, on volume of 1,791,512 shares (0.4× its 3-month average); market value about $700.0M.

What happened

Nexqual found no SEC filing, earnings release, analyst rating change or insider trade for PRME on Tuesday, November 10, 2026 or November 9, 2026. The move may reflect news, sector or market moves, or trading flows that these sources do not capture.

More on PRME

PRME stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 10, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:31 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:31 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt